Lacosamide Tablet
Product Images NDC 71921-220

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 71921-220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Figure1)

Bar chart depicting median percentage seizure reduction from baseline comparing placebo and Lacosamide tablets at different doses across three clinical studies. The x-axis represents treatment groups by dose, and the y-axis shows seizure reduction percentages, with Lacosamide doses generally showing higher reduction than placebo in each study.*

FDA Label Image

Fig2 (Figure2)

A responder rate chart depicting improvement and worsening in patients treated with lacosamide tablets at doses of 200 mg/day, 400 mg/day, and 600 mg/day, compared with placebo. The x-axis shows percent of patients, and the y-axis shows responder rate ranging from -100% (worsening) to 100% (improvement). The graph compares responder rates for placebo and three different lacosamide dosages with sample sizes indicated for each group.*

FDA Label Image

Container-label-100mg-60s-site-iii (Lacosamide 100 mg Site Iii)

Lacosamide Tablets, USP 100 mg oral tablet label with 60 tablets per bottle. The label includes storage instructions, pharmacist attention note about the medication guide, and manufacturing details by Indoco Remedies Ltd. for Florida Pharmaceutical Products, LLC.*

FDA Label Image

Container-label-150mg-60s-site-iii (Lacosamide 150 mg Site Iii)

Lacosamide Tablets, USP 150 mg oral tablets bottle label showing the active ingredient strength, package size of 60 tablets, and manufacturer information for Florida Pharmaceutical Products, LLC. The label includes storage instructions, a barcode, and an NDC number 71921-222-06.*

FDA Label Image

Container-label-200mg-60s-site-iii (Lacosamide 200 mg Site Iii)

Lacosamide Tablets, USP 200 mg oral tablets label for prescription use. The label includes storage instructions, manufacturer details (Indoco Remedies Ltd. in India), and the labeler (Florida Pharmaceutical Products, LLC). The package contains 60 tablets and indicates the necessity for a Medication Guide.*

FDA Label Image

Container-label-50mg-60s-site-iii (Lacosamide 50 mg Site Iii)

Label for Lacosamide Tablets USP 50 mg, oral tablets, with 60 tablets per container. Manufactured by Indoco Remedies Ltd., India and labeled for Florida Pharmaceutical Products, LLC. The label includes storage instructions and a note for pharmacists regarding the medication guide. It displays the NDC 71921-220-06 and barcodes.*

FDA Label Image

Str (Structure)

Chemical structure diagram of lacosamide, the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.